Expression of prolactin receptor and prolactin in normal and malignant thyroid: A tissue microarray study

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Endocrine pathology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/S12022-006-0009-XPMID 17525486
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human relevance of rodent prolactin‐induced non‐genotoxic mammary carcinogenesis: prolactin involvement in human breast cancer and significance for toxicology risk assessments

  2005cited by this paper
• Medullary thyroid carcinoma arises in the absence of prolactin signaling.

  2005cited by this paper
• Development and potential clinical uses of human prolactin receptor antagonists.

  2005cited by this paper
• Prolactin inhibits apoptosis of ovarian carcinoma cells induced by serum starvation or cisplatin treatment

  2005cited by this paper
• Plasma Prolactin Concentrations and Risk of Postmenopausal Breast Cancer

  2004cited by this paper
• Prolactin acts as a potent survival factor for human breast cancer cell lines

  2004cited by this paper
• Interactions of Prolactin and Growth Hormone (GH) in the Regulation of Mammary Gland Function and Epithelial Cell Survival

  2004cited by this paper
• Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice

  2003cited by this paper
• Molecular Classification of Breast Carcinomas Using Tissue Microarrays

  2003cited by this paper
• Prolactin induces ERalpha-positive and ERalpha-negative mammary cancer in transgenic mice.

  2003cited by this paper
• Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers.

  2002cited by this paper
• Expression of functional prolactin and its receptor in human colorectal cancer

  2002cited by this paper
• Prolactin as an autocrine/paracrine growth factor in human cancer.

  2002cited by this paper
• A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice.

  2001cited by this paper
• Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR.

  2001cited by this paper
• Tissue microarrays for rapid linking of molecular changes to clinical endpoints.

  2001cited by this paper
• Amplification of tissue by construction of tissue microarrays.

  2001cited by this paper
• Validation of Tissue Microarray Technology in Breast Carcinoma

  2000cited by this paper
• The role of prolactin and growth hormone in breast cancer

  2000cited by this paper
• Effects of hyperprolactinemia on calcitonin secretion in male rats.

  1999cited by this paper
• Constitutive Activation of the Prolactin Receptor Results in the Induction of Growth Factor-independent Proliferation and Constitutive Activation of Signaling Molecules*

  1999cited by this paper
• Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice.

  1998cited by this paper
• Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice.

  1997cited by this paper
• Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells.

  1996cited by this paper
• Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects.

  1996cited by this paper
• Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: correlation with plasma prolactin.

  1995cited by this paper
• Prolactin-immunoglobulin G complexes from human serum act as costimulatory ligands causing proliferation of malignant B lymphocytes.

  1995cited by this paper
• Prolactin synthesis and secretion by human breast cancer cells.

  1995cited by this paper
• Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.

  1995cited by this paper
• Calcium homeostasis in normal pregnancy and puerperium. A longitudinal study.

  1994cited by this paper
• Interrelationship of prolactin and its receptor in carcinoma of colon and rectum: A preliminary report

  1994cited by this paper
• Human promyelocytic cell line HL60 has the specific binding sites for prolactin and its ornithine decarboxylase, DNA synthesis and cellular proliferation are induced by prolactin.

  1993cited by this paper
• Characterization of a monoclonal antibody against human prolactin receptors

  1993cited by this paper
• Prolactin‐Stimulated Mitogenesis of Cultured Astrocytes Is Mediated by a Protein Kinase C‐Dependent Mechanism

  1993cited by this paper
• The prolactin/growth hormone receptor family.

  1991cited by this paper
• Evaluation of a peptide family encoded by the calcitonin gene in selected healthy pregnant women. A longitudinal study.

  1990cited by this paper
• A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain.

  1989cited by this paper
• Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family.

  1988cited by this paper
• Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies.

  1985cited by this paper
• Interrelations of calcium-regulating hormones during normal pregnancy.

  1981cited by this paper
• Prolactin-stimulated growth of cell cultures established from malignant Nb rat lymphomas.

  1980cited by this paper
• A physiological role for calcitonin: protection of the maternal skeleton.

  1979cited by this paper
• Calcium metabolism in normal pregnancy: a longitudinal study.

  1979cited by this paper
• Immunoreactive calcitonin in the mother, neonate, child and adult.

  1975cited by this paper

• Relationship between thyroid nodule, prolactin, and thyroid peroxidase antibody levels: A case-control study

  2025cites this paper
• Multi-disease transcriptomic analysis of sex hormone genes reveals a novel prognostic model for thyroid cancer with breast cancer correlations

  2025cites this paper
• Serum sex hormones correlate with pathological features of papillary thyroid cancer

  2023cites this paper
• The impact of oral hormonal contraception on metformin action on hypothalamic‐pituitary‐thyroid axis activity in women with diabetes and prediabetes: A pilot study

  2020cites this paper
• Nodular Thyroid Disease and Papillary Thyroid Carcinoma in Functional Pituitary Adenomas

  2018cites this paper
• Differentiated thyroid cancer in patients with prolactinoma.

  2016cites this paper
• The paired box transcription factor Pax8 is essential for function and survival of adult thyroid cells.

  2014cites this paper
• Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model.

  2013cites this paper
• Detection of Survivin and COX-2 in Thyroid Carcinoma: Anaplastic Carcinoma Shows Overexpression of Nuclear Survivin and Low COX-2 Expression

  2012cites this paper
• Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors

  2009cites this paper
• Expression of decoy receptor 3 in liver tissue microarrays.

  2008cites this paper